Brief: Chordate Medical Announces Patent Protection For Headache Treatment In USA
June 29 (Reuters) - Chordate Medical Holding publ AB CMHM.ST :
* HAS BEEN NOTIFIED OF THE GRANTING OF ADDITIONAL PATENT PROTECTION FOR HEADACHE TREATMENT
IN THE
UNITED STATES
Source text for Eikon: ID:nBQN1VhR8s
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln